Ramazan Ulu

Ramazan Ulu

Auto-generated profile, based on publicly available information

Ramazan Ulu

Department of Internal Medicine, Adıyaman University, Nephrology Clinic, Adıyaman, Türkiye

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2021 in Balkan Medical Journal
Verified
Journal Article
Open access
KGKursat Gundogan
Kursat Gundogan
İAİsmail Hakkı Akbudak
İsmail Hakkı Akbudak
PHPervin Hancı
Pervin Hancı
BHBurcin Halaci
Burcin Halaci
STSahin Temel
Sahin Temel
ATArzu Topeli
Arzu Topeli
There are limited data on the long-term outcomes of COVID-19 from different parts of the world. To determine risk factors of 90-day mortality in critically ill patients in Turkish intensive care units (ICUs), with respiratory failure. Retrospective, observational cohort. Patients with laboratory-confirmed COVID-19 and who had been followed up in the ICUs with respiratory failure for more than 24 hours were included in the study. Their demographics, clinical characteristics, laboratory variables, treatment protocols, and survival data were recorded. A total of 421 patients were included. The median age was 67 (IQR: 57-76) years, and 251 patients (59.6%) were men. The 90-day mortality rate was 55.1%. The factors independently associated with 90-day mortality were invasive mechanical ventilation (IMV) (HR 4.09 [95% CI: [2.20-7.63], P < .001), lactate level >2 mmol/L (2.78 [1.93-4.01], P < .001), age ≥60 years (2.45 [1.48-4.06)], P < .001), cardiac arrhythmia during ICU stay (2.01 [1.27-3.20], P = .003), vasopressor treatment (1.94 [1.32-2.84], P = .001), positive fluid balance of ≥600 mL/day (1.68 [1.21-2.34], P = .002), PaO2/FiO2 ratio of ≤150 mmHg (1.66 [1.18-2.32], P = .003), and ECOG score ≥1 (1.42 [1.00-2.02], P = .050). Long-term mortality was high in critically ill patients with COVID-19 hospitalized in intensive care units in Turkey. Invasive mechanical ventilation, lactate level, age, cardiac arrhythmia, vasopressor therapy, positive fluid balance, severe hypoxemia and ECOG score were the independent risk factors for 90-day mortality.


23 March 2024 in Health Information Science and Systems
Verified
Journal Article
Open access
PDF file
KGKadime Gogebakan
Kadime Gogebakan
RURamazan Ulu
Ramazan Ulu
RARahib Abiyev
Rahib Abiyev
MŞMelike Şah
Melike Şah
According to the World Health Organization (WHO) data from 2000 to 2019, the number of people living with Diabetes Mellitus and Chronic Kidney Disease (CKD) is increasing rapidly. It is observed that Diabetes Mellitus increased by 70% and ranked in the top 10 among all causes of death, while the rate of those who died from CKD increased by 63% and rose from the 13th place to the 10th place. In this work, we combined the drug dose prediction model, drug-drug interaction warnings and drugs that potassium raising (K-raising) warnings to create a novel and effective ontology-based assistive prescription recommendation system for patients having both Type-2 Diabetes Mellitus (T2DM) and CKD. Although there are several computational solutions that use ontology-based systems for treatment plans for these type of diseases, none of them combine information analysis and treatment plans prediction for T2DM and CKD. The proposed method is novel: (1) We develop a new drug-drug interaction model and drug dose ontology called DIAKID (for drugs of T2DM and CKD). (2) Using comprehensive Semantic Web Rule Language (SWRL) rules, we automatically extract the correct drug dose, K-raising drugs, and drug-drug interaction warnings based on the Glomerular Filtration Rate (GFR) value of T2DM and CKD patients. The proposed work achieves very competitive results, and this is the first time such a study conducted on both diseases. The proposed system will guide clinicians in preparing prescriptions by giving necessary warnings about drug-drug interactions and doses.

1 December 2001 in Journal of Surgical Research
Verified
Journal Article
Closed access
IAIsmet Aydogdu
Ismet Aydogdu
RSRAMAZAN SARI
RAMAZAN SARI
RURamazan Ulu
Ramazan Ulu
ASAlper Sevinc
Alper Sevinc

1 December 2018
Verified
Closed access
PDF file
RURamazan Ulu
Ramazan Ulu
SDSemih Dalkilic
Semih Dalkilic
NGNevzat Gozel
Nevzat Gozel
FKFaruk Kilinc
Faruk Kilinc
ADAyhan Dogukan
Ayhan Dogukan

4 September 2026 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MAMESUDE SEDA AYDOĞDU
MESUDE SEDA AYDOĞDU
RURamazan Ulu
Ramazan Ulu
MYMeltem Yardim
Meltem Yardim
SASÜLEYMAN AYDIN
SÜLEYMAN AYDIN
Objective: Chronic kidney disease (CKD) is characterized by progressive decline in glomerular filtration rate (GFR) and is associated with activation of neurohormonal pathways, including the arginine vasopressin system. Copeptin, the C-terminal fragment of pre-pro-vasopressin, has emerged as a stable surrogate marker of vasopressin activity. This cross-sectional study compared serum copeptin levels across clinically distinct study groups and evaluated their associations with renal and biochemical parameters. Methods: The study included 120 participants: 30 healthy controls and 90 patients with CKD, comprising stage 3 CKD, stage 4 CKD, and end-stage kidney disease (ESKD) receiving maintenance hemodialysis groups ( n = 30 each). In patients receiving maintenance hemodialysis, fasting blood samples were obtained immediately before the scheduled dialysis session. Serum copeptin concentrations were measured using an enzyme-linked immunosorbent assay (ELISA). Renal function was assessed using 24-hour urinary creatinine clearance; in patients receiving maintenance hemodialysis, these values were interpreted as approximate estimates of residual kidney function. Intergroup comparisons were performed using one-way ANOVA, and correlations were analyzed using Pearson’s test. A two-tailed p value < 0.05 was considered statistically significant. Results: Serum copeptin levels were significantly higher in the hemodialysis group than in the control, stage 3 CKD, and stage 4 CKD groups (overall p < 0.001). No significant differences were observed among the control, stage 3 CKD, and stage 4 CKD groups. Copeptin was negatively correlated with 24-hour urinary creatinine clearance ( r = − 0.237, p < 0.01) and positively correlated with creatinine, parathyroid hormone, and glucose. No significant correlations were observed with C-reactive protein, calcium, phosphorus, or urea. Conclusion: In this cohort, copeptin levels were significantly elevated in patients receiving maintenance hemodialysis, whereas no significant differences were observed between controls and patients with stage 3 or stage 4 CKD. Because non-dialysis stage 5 CKD was not evaluated, these findings should be considered exploratory. Larger prospective studies incorporating appropriate multivariable analyses and longitudinal follow-up are required to clarify the significance of copeptin in CKD.